Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × liposomal doxorubicin × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 11 Breast Neoplasms 9 Triple Negative Breast Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Sarcoma 3 Sarcoma, Kaposi 2 Sarcoma, Ewing 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Acquired Immunodeficiency Syndrome 2 AIDS-related Kaposi sarcoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Rhabdomyosarcoma 1 Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Multiple Myeloma 1 Macular dystrophy, corneal type 1 1

Interventions

Rituximab 8 Vemurafenib 4 Cladribine 4 obinutuzumab 3 Specimen Handling 3 Cyclophosphamide 3 Biopsy 3 ibrutinib 2 binimetinib 2 Lenalidomide 2 Diphenhydramine 2 CT-P10 2 Bendamustine Hydrochloride 2 Acetaminophen 2 venetoclax 1 tovorafenib 1 polatuzumab vedotin 1 pembrolizumab 1 immunotoxin HA22 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 cc-486 1 brexucabtagene autoleucel 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Spinal Puncture 1 Sodium Chloride 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡